title: The plating of rat scar myofibroblasts on matrigel unmasks a novel phenotype; the self assembly of lumen-like structures.
abstract: During tissue healing, the primary role of myofibroblasts involves the synthesis and deposition of collagen. However, it has also been reported that selective populations of myofibroblasts can acquire the phenotype and/or differentiate to other cells types. The present study tested the hypothesis that myofibroblasts isolated from the scar of the ischemically damaged rat heart can recapitulate an endothelial cell-like response when plated in a permissive in vitro environment. Scar myofibroblasts, neonatal and adult ventricular fibroblasts express smooth muscle α-actin, collagen α(1) type 1 and a panel of pro-fibrotic and pro-angiogenic peptide growth factor mRNAs. Myofibroblasts plated alone on matrigel led to the self assembly of lumen-like structures whereas neonatal and adult rat ventricular fibroblasts were unresponsive. Myofibroblasts labeled with the fluorescent cell tracker CM-DiI were injected in the viable myocardium of 3-day post-myocardial infarcted Sprague-Dawley rats and sacrificed 7 days later. Injected CM-DiI-labeled myofibroblasts were detected predominantly in the peri-infarct/infarct region, highlighting their migration to the damaged region. However, engrafted myofibroblasts in the peri-infarct/infarct region were unable to adopt an endothelial cell-like phenotype or lead to the de novo formation of CM-DiI-labeled blood vessels. The non-permissive nature of the infarct region may be attributed at least in part to the presence of growth-promoting stimuli as TGF-β and the β-adrenergic agonist isoproterenol inhibited the self assembly of lumen-like structures by myofibroblasts. Thus, when plated in a permissive in vitro environment, scar myofibroblasts can self assemble and form lumen-like structures providing an additional novel phenotype distinguishing this population from normal ventricular fibroblasts.
authors.affiliation: Département de Physiologie, Université de Montréal, Montréal, Québec, Canada.
authors.forename: Viviane
authors.initials: V
authors.lastname: El-Helou
authors.forename: Hugues
authors.initials: H
authors.lastname: Gosselin
authors.forename: Louis
authors.initials: L
authors.lastname: Villeneuve
authors.forename: Angelino
authors.initials: A
authors.lastname: Calderone
mesh_terms: D000199:Actins / Q000096:biosynthesis; D000818:Animals; D002232:Carbocyanines; D018929:Cell Culture Techniques; D002454:Cell Differentiation; D002469:Cell Separation; D002478:Cells, Cultured; D002921:Cicatrix; D003094:Collagen; D024042:Collagen Type I / Q000096:biosynthesis; D000090602:Collagen Type I, alpha 1 Chain; D004338:Drug Combinations; D042783:Endothelial Cells / Q000378:metabolism / Q000502:physiology; D005347:Fibroblasts; D006352:Heart Ventricles / Q000473:pathology*; D036341:Intercellular Signaling Peptides and Proteins / Q000096:biosynthesis; D007545:Isoproterenol / Q000494:pharmacology; D007797:Laminin; D008297:Male; D009203:Myocardial Infarction / Q000378:metabolism / Q000473:pathology; D017202:Myocardial Ischemia / Q000378:metabolism / Q000473:pathology*; D009206:Myocardium / Q000473:pathology*; D058628:Myofibroblasts / Q000166:cytology / Q000502:physiology*; D010641:Phenotype; D011509:Proteoglycans; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D016212:Transforming Growth Factor beta
chemical_list: D000199:Actins; C101089:CM-DiI; D002232:Carbocyanines; D024042:Collagen Type I; D000090602:Collagen Type I, alpha 1 Chain; D004338:Drug Combinations; D036341:Intercellular Signaling Peptides and Proteins; D007797:Laminin; D011509:Proteoglycans; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; C059485:matrigel; D003094:Collagen; D007545:Isoproterenol